InsidersTradesSigma
Browse the full record of transactions filed by Neumann Mark, Chief Financial Officer. Director active across 1 companies, notably Intra-Cellular Therapies, Inc.. In total, 7 filings have been logged. The latest transaction was filed on 8 April 2022 (Levée d'options). Regulator: SEC (Form 4). All data is openly available.
7 of 7 declarations
Mark Alan Jeffries serves as Chief Financial Officer at Select Bancorp, Inc. He is responsible for the company's financial management, including financial planning, accounting, and risk management. Mark plays a vital role in developing financial strategies that support the growth and sustainability of Select Bancorp.